See full prescribing information for BYETTA.<br/> <br/>BYETTA® (exenatide) injection, for subcutaneous use<br/>Initial U.S. Approval: 2005</title>

Dec 19, 2024 · Drug manufacturer AstraZeneca (AZ) recently notified the U.S. Food and Drug Administration (FDA) that it discontinued Bydureon BCise and Byetta. Bydureon BCise was …

AstraZeneca medications The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific …

AZ&Me™ is designed to help qualifying people without insurance and those on Medicare who are having trouble affording their AstraZeneca medications. We provide financial assistance to …

BYETTA is injected twice a day, the pen contains enough medicine for 30 days. You do not have to measure any doses, the pen measures each dose for you. DO NOT TRANSFER THE …

Sep 19, 2014 · AstraZeneca today announced 28-week results from DURATION-NEO-1, a Phase III study comparing an investigational formulation of exenatide once-weekly suspension for …

This web site is intended to help healthcare professionals practicing in the US and AstraZeneca authorized persons find scientifically balanced, evidence-based information about …

Sep 23, 2022 · BYETTA is used to improve blood sugar control in adults with type 2 diabetes in combination with metformin and/or a sulfonylurea when metformin and/or a sulfonylurea plus …

Nov 1, 2024 · AstraZeneca Pharmaceuticals LP: BYETTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see...

BYETTA enhances glucose-dependent insulin secretion by the pancreatic beta-cell, suppresses inappropriately elevated glucagon secretion, and slows gastric emptying.